Literature DB >> 7299463

Pineal tumors in children and adolescents. Treatment by CSF shunting and radiotherapy.

E O Abay, E R Laws, G L Grado, J E Bruckman, G S Forbes, M R Gomez, M Scott.   

Abstract

Tumors of the pineal region account for 3% to 8% of pediatric intracranial tumors. The treatment of such tumors has been in a state of flux between conservative therapy (cerebrospinal fluid shunting and radiotherapy) and direct surgical removal. A brief history and review of the literature with analysis of both approaches is given, and the Mayo Clinic's experience with conservative treatment of tumors in the pineal region in patients 20 years old and younger (27 cases) is studied and analyzed. The series comprises 21 boys and six girls, with an age range of 1 to 20 years (mean 13.7 years). Follow-up examinations are complete and range from 1 to 24 years, with a mean follow-up period of 7.8 years. The median survival time for these patients treated with shunt and radiotherapy is 17.7 years. There was no mortality from treatment and complications were rare. The details of the clinical presentation, diagnostic findings, pathology, therapy, recurrence, and survival are presented. All patients under 6 years of age (six cases) had recurrences, 50% in other areas in the brain and 50% in the spinal cord, perhaps pointing to the need for whole-brain and spinal-axis irradiation in patients in this age group. The results of this study of the conservative approach form a standard against which results of any other type of therapy may be compared.

Entities:  

Mesh:

Year:  1981        PMID: 7299463     DOI: 10.3171/jns.1981.55.6.0889

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

Review 1.  Surgical approaches to pineal region tumors.

Authors:  K M Little; A H Friedman; T Fukushima
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

2.  Clinical outcomes of adult patients with primary intracranial germinomas treated with low-dose craniospinal radiotherapy and local boost.

Authors:  M Foote; B-A Millar; A Sahgal; C Ménard; D Payne; W Mason; N Laperriere
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

Review 3.  Microsurgical resection of pineal region tumors.

Authors:  Adam M Sonabend; Stephen Bowden; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2016-05-19       Impact factor: 4.130

4.  An unusual case of primary central nervous system germinoma with meningeal dissemination.

Authors:  Yasuhiro Takeshima; Shuichi Yamada; Yasushi Motoyama; Young-Su Park; Hiroyuki Nakase
Journal:  Childs Nerv Syst       Date:  2012-08-31       Impact factor: 1.475

5.  Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16).

Authors:  J Yoshida; K Sugita; T Kobayashi; K Takakura; N Shitara; M Matsutani; R Tanaka; H Nagai; H Yamada; J Yamashita
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Pineal germinoma: diagnosis, treatment and tumor response.

Authors:  S Ferla; S Spartà; R Giordano; P L Zorat; G Marin; G Meneghetti
Journal:  Ital J Neurol Sci       Date:  1987-06

7.  Pinealomas and germinomas in children.

Authors:  J R Farwell; J T Flannery
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

8.  Germ cell tumor in the hypothalamo-neurohypophysial region: clinical features and treatment.

Authors:  S Nishio; T Inamura; I Takeshita; M Fukui; K Kamikaseda
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

9.  Treatment strategy for intracranial primary pure germinoma.

Authors:  Kyu-Won Shim; Eun Kyung Park; Yoon-Ho Lee; Chang-Ok Suh; Jaeho Cho; Joong-Uhn Choi; Dong-Seok Kim
Journal:  Childs Nerv Syst       Date:  2012-09-11       Impact factor: 1.475

Review 10.  Cavernous haemangioma of the pineal region.

Authors:  D Lombardi; B W Scheithauer; R M Villani; M Giovanelli; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.